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Abstract
Background: The high mortality of hip fracture patients is well documented, but sex- and cause-specific mortality
after hip fracture has not been extensively studied. The purpose of the present study was to evaluate mortality and
cause of death in patients after hip fracture surgery and to compare their mortality and cause of death to those in
the general population.
Methods: Records of 428 consecutive hip fracture patients were collected on a population-basis and data on the
general population comprising all Finns 65 years of age or older were collected on a cohort-basis. Cause of death
was classified as follows: malignant neoplasms, dementia, circulatory disease, respiratory disease, digestive system
disease, and other.
Results: Mean follow-up was 3.7 years (range 0-9 years). Overall 1-year postoperative mortality was 27.3% and
mortality after hip fracture at the end of the follow-up was 79.0%. During the follow-up, age-adjusted mortality
after hip fracture surgery was higher in men than in women with hazard ratio (HR) 1.55 and 95% confidence
interval (95% CI) 1.21-2.00. Among hip surgery patients, the most common causes of death were circulatory
diseases, followed by dementia and Alzheimer’s disease. After hip fracture, men were more likely than women to
die from respiratory disease, malignant neoplasm, and circulatory disease. During the follow-up, all-cause age- and
sex-standardized mortality after hip fracture was 3-fold higher than that of the general population and included
every cause-of-death category.
Conclusion: During the study period, the risk of mortality in hip fracture patients was 3-fold higher than that in
the general population and included every major cause of death.
Background
Hip fracture is the most serious consequence of falling
in older people with osteoporosis; 87% to 96% of hip
fracture patients are 65 years of age or older [1,2]. Hip
fractures are associated with increased mortality rates;
the magnitude of the increased mortality and the length
of its duration, however, are unclear. One study stated
that survival declines soon after hip fracture, but there-
after parallels the expected survival of the general popu-
lation [3]. A recent systematic epidemiologic review,
however, showed that patients are at increased risk for
premature death for many years after hip fracture [4].
Excess mortality after hip fracture may be linked to
complications following the fracture, such as pulmonary
embolism [5], infections [2,6], and heart failure [2,6].
Factors associated with the risk of falling and sustaining
osteoporotic fractures may also be responsible for the
excess mortality [1,7]. Excess mortality after fracture
may be due to the individual characteristics of the per-
son sustaining the hip fracture [8]; e.g., low-bone density
is associated with increased non-trauma mortality, even
without fractures. Despite numerous mortality studies,
further analysis of mortality and cause of death is
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any medium, provided the original work is properly cited.important to identify the risk factors for death following
trauma and to anticipate complications [9].
Although several studies report excess mortality in hip
fracture patients compared to controls [1] the issue
remains under-recognized in many countries. Further-
more, sex- and cause-specific mortality after hip fracture
has not been extensively investigated [6]. The aims of
the present population-based study were to evaluate pat-
terns of death by sex and hip fracture type and to evalu-
ate mortality after hip fracture compared to the general
population with a specific focus on the cause of death.
Methods
The data analyzed in the present study were extracted from
the records of hip fracture patients collected on a popula-
tion-basis in the province of Satakunta in the western
coastal region of Finland and from statistics on the general
population collected on a cohort-basis of all persons 65 of
age or older living in Finland. The referral area for hip frac-
ture patients was the Satakunta Hospital District, which has
a population of 235,580 (December 31, 1999). The number
of residents 65 years of age or older in this district totalled
39,910 at the time of the study (16.9% of the population).
Population figures for the hospital district and the entire
country on December 31 in 1998 and in 1999 were
obtained from the Official Statistics of Finland [10].
Patients
The Finnish Hospital Discharge Register was used to
retrieve data on people 65 years of age or older living in
the Satakunta area who underwent hip fracture surgery
during the 2-year period between January 1, 1999, and
December 31, 2000. Of these, all patients who resided in
the district during the study period were included in the
study, irrespective of the operating hospital location.
Patients who underwent surgery in the study area but
did not reside there were excluded. The total number of
eligible patients was 461. Of these patients, valid infor-
mation could be collected for 428 patients. Thirty-three
patients (10 men, 23 women) were excluded from the
study due to missing death information. Of the 428
patients included in the present study, fracture-type data
were missing in 3 men and 18 women. Data regarding
preoperative comorbidities and operation type were ret-
rospectively collected from the original patient records.
Hip fractures were classified as cervical or trochanteric
based on examination of the original radiographs.
General Population
The general population comprised people who resided
in Finland between January 1, 1999, and December 31,
2000, that were 65 of age or older during this period.
Population data were divided into three age categories
(65-74, 75-84, and ≥85 years).
Deaths
Data on deaths and cause of death were retrieved from
the Official Cause of Death Statistics of Finland [10].
Deaths in Finland must be reported immediately either
to a physician or to the police. A death certificate is
issued by a physician and delivered to the Provincial
State Office, where it is checked and forwarded to Sta-
tistics Finland. The verification is made by a forensic
pathologist or a specifically trained provincial physician.
Death certificates are used at Statistics Finland to com-
pile cause-of-death statistics [10].
Cause-of-death statistics are compiled from data
obtained from death certificates, which are supplemented
with data from the population information system of the
Population Register Centre. These statistics cover persons
who have died in Finland or abroad during the calendar
year and who at the time of death were domiciled in Fin-
land. Cause-of-death statistics contain data on deaths by
cause of death, age, sex, marital status, and other demo-
graphic variables and data on the circumstances of the
death [10]. The Finnish Official Cause-of-Death Statistics
are in practice 100% complete, as each death, its certifi-
cate, and the corresponding personal information in this
computerized population register is crosschecked [10].
Mortality
Mortality of the hip fracture patients was assessed at the
end of the follow-up, on December 31, 2007. Cause of
death was classified according to the International Sta-
tistical Classification of Diseases and Related Health
Problems (ICD10) [11] as follows: malignant neoplasms
(ICD10 codes C00-C97); dementia (including Alzhei-
mer’s disease, ICD10 codes F01, F03, G30, R54); circula-
tory system disease (ICD10 codes I00-I42.5, I42.7-I99
[cerebrovascular disease included]); respiratory system
disease (ICD10 codes J00-J64, J66-J99); digestive system
disease, excluding alcohol-related disease (ICD10 codes
K00-K93, excluding K70, K86.0, K86.01, K86.08); and
other (ICD10 codes not mentioned above). Preoperative
comorbidities were similarly classified.
Mortality of the general population was assessed on
December 31 of each year from 1999 to 2007. For com-
parison with the general population, hip fracture
patients were divided into three age categories (65-74,
75-84, and ≥85 years) and their annual mortality by sex
was assessed from 1999 to 2007 to calculate age- and
sex-standardized mortality. The person years (PY) were
calculated by sex, age category, and calendar year.
The study protocol was approved by the Ethics Com-
mittee of the Satakunta Hospital District.
Statistical analysis
Sex differences of continuous variables were compared
using a two-sample t-test. A chi-square test was used to
Panula et al. BMC Musculoskeletal Disorders 2011, 12:105
http://www.biomedcentral.com/1471-2474/12/105
Page 2 of 6analyze the differences in baseline characteristics
between men and women. The age-adjusted differences
in mortality between sexes were analyzed with Cox’s
proportional hazards model. The age- and sex-adjusted
differences in mortality between hip fracture types (n =
407) were analyzed with Cox’s proportional hazards
model. The survival time was counted in calendar days
and expressed as person years from the day of the
operation to the day of death or to the end of the fol-
low-up. Results are presented using hazard ratios (HR)
with 95% confidence intervals (95% CI). Annual age-
and sex-standardized mortality of hip fracture patients
was calculated for three age categories (65-74, 75-84,
and ≥85 years) with a direct method based on the gen-
eral population in Finland. A p-value of less than 0.05
was considered statistically significant. Statistical ana-
lyses were performed using the SAS System for Win-
dows, version 9.1 (SAS Institute Inc, Cary, NC).
Results
Patient characteristics
Patient characteristics ares h o w ni nT a b l e1 .At o t a lo f
428 hip fracture patients that were eligible for this study
were operated on between January 1, 1999 and Decem-
ber 31, 2000, and the follow-up lasted until December
31, 2007. The mean follow-up period was 3.7 years
(range 0-9 years). Most patients were women (n = 325,
75.9%), and they were older than the men (mean ages
82.7 [women], 79.0 [men] years; p < 0.001). Distribu-
tions of fracture and operation types were similar
between sexes. The majority of fractures were cervical,
and the numbers of prostheses and internal fixations
were equivalent between groups. The majority of the
patients (75%) died in a hospital, health center, or other
care facility. Home or another dwelling was the place of
death for 7 men (8.1%) and 7 women (2.8%; p = 0.031).
The 21 patients (3 men and 18 women) with missing
f r a c t u r e - t y p ed a t aw e r eo l d e rt h a nt h ep a t i e n t sw i t h
identified fracture-type data (84.8 vs. 81.6 years, p =
0.041).
Overall mortality (cumulative number of deaths) was as
follows: at 30 days after surgery, n = 45 (10.5%); at 6
months, n = 92 (21.5%); at 1 year, n = 117 (27.3%); at 3
years, n = 209 (48.8%); at 7 years, n = 315 (73.6%); and on
December 31, 2007 (end of follow-up), n = 338 (79.0%).
Circulatory system disease was the most common cause of
death (n = 149, 44.1%), followed by dementia and Alzhei-
mer’s disease (n = 53, 15.7%), respiratory system disease (n
= 44, 13.0%), malignant neoplasms (n = 31, 9.2%), digestive
system disease (n = 16, 4.7%), and other (n = 45, 13.3%).
Table 1 Patient Characteristics (n = 428)
Men Women
n(%) n(%) p-
value
103
(24.1)
325
(75.9)
Age in years; mean (SD) 79.0
(7.0)
82.7
(6.7)
<
0.001
Type of fracture* 0.421
Cervical fracture 67
(67.0)
192
(62.5)
Trochanteric fracture 33
(33.0)
115
(37.5)
Type of operation*
Prosthesis 54
(52.4)
174
(53.7)
0.821
ORIF 49
(47.6)
150
(46.3)
Preoperative morbidity
Circulatory disease 64
(62.1)
227
(69.9)
0.144
Respiratory disease 18
(17.5)
25 (7.7) 0.004
Malignancy 17
(16.5)
23 (7.1) 0.004
Dementia, Alzheimer’s disease 15
(14.6)
93 (28.6) 0.004
Digestive disease 6 (5.8) 25 (7.7) 0.524
Other 17
(16.5)
45 (13.9) 0.504
Follow-up time†; mean (SD) 3.3 (3.1) 3.9 (3.0) 0.077
Died during follow-up 86
(83.5)
252
(77.5)
0.196
Underlying cause of death
Circulatory disease 39
(37.9)
110
(33.9)
0.456
Respiratory disease 13
(12.6)
31 (9.5) 0.369
Malignancy 12
(11.7)
19 (5.9) 0.048
Dementia, Alzheimer’s disease 10 (9.7) 43 (13.2) 0.344
Digestive disease 2 (1.9) 14 (4.3) 0.270
Other 10 (9.7) 35 (10.8) 0.760
Place of death
Hospital, health centre, other care
facility
65
(75.6)
190
(75.4)
0.973
Home, dwelling 7 (8.1) 7 (2.8) 0.031
Other (e.g., old people’s home) 14
(16.3)
54 (21.4) 0.304
Unknown 0 (0) 1 (0.4) 0.559
SD = standard deviation
ORIF = open reduction and internal fixation
* Type of fracture unknown for 21 patients and type of operation unknown
for 1 patient
† Follow-up years from operation to death or end of 2007
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fracture patients (n = 428)
The risk of death in men compared with women was
increased during the follow-up with HR 1.55 (95% CI
1.21-2.00, p < 0.001).
D u r i n gt h ee n t i r ef o l l o w - u p( 0 - 9y e a r s ) ,s o m ed i f f e r -
ences in age-adjusted cause-of-death patterns between
sexes were noted: men were more likely than women to
die from respiratory system disease (HR 2.17, 95% CI
1.11-4.24, p = 0.023), from malignant neoplasms (HR
2.15, 95% CI 1.02-4.54, p = 0.044), and from circulatory
system disease (HR 1.71, 95% CI 1.18-2.49, p = 0.005).
Age-adjusted analysis of cause of death showed no sex
differences in death from dementia and Alzheimer’s dis-
ease, digestive system disease, or other causes (data not
shown).
Fracture-type differences in mortality and cause of death
in hip fracture patients (n = 407)
In age- and sex-adjusted analyses, no differences in mor-
tality or cause of death were noted between fracture
types (data not shown).
Comparisons of mortality and cause of death between
hip fracture patients and the general population
During the follow-up from January 1, 1999, to Decem-
ber 31, 2007, age- and sex-standardized mortality was
approximately 3-fold higher in hip fracture patients
than in the general population (Table 2). When
assessed by cause of death, age- and sex-standardized
mortality was 2.5 to 8.4-fold higher in patients com-
pared to the general population in each cause-of-death
category (Table 2).
Discussion
The present population-based study showed that during
a 9-year follow-up, the age- and sex-standardized all-
cause mortality of hip fracture patients was 3-fold
higher than that of the general population. The
increased mortality was related to every cause-of-death
category, i.e., malignant neoplasm; dementia; diseases of
circulatory, respiratory, and digestive systems; and other.
Our study area lies in the western coast of Finland;
there are regional differences of mortality in favor of
Western Finland compared to Eastern Finland [12]. This
aspect enhances the mortality difference between the
hip fracture patients and the general population of our
study. Of hip fracture patients, men had significantly
higher mortality than women during the follow-up. Men
were more likely to die from respiratory system disease,
malignant neoplasms, and circulatory system disease
after hip fracture than women. Sex differences in cause
of death after hip fracture have not been systematically
studied [6]. To our knowledge, there are no studies of
mortality after hip fracture surgery with follow-up peri-
ods of several years in which cause of death was ana-
lyzed in association with sex.
In the present study, the increased age-adjusted mor-
tality in men compared to women was obvious immedi-
ately after the hip fracture operation and persisted until
the end of the follow-up, which is consistent with pre-
vious studies [6,13,14]. The reasons for the sex differ-
ences are unclear, although men tend to be sicker and
frailer than women at the time of fracture [15]. Greater
impairments in activities of daily living, mobility, and
walking speed have been observed in male hip fracture
patients compared to women. This may indicate a
greater loss of physiologic reserve after hip fracture in
men than in women and, hence, a greater risk of death
[14].
This study revealed differences between sexes in cause
of death after hip fracture. Men in our study were more
likely than women to die from respiratory diseases. At
baseline, respiratory diseases were more common in
m e nt h a ni nw o m e n .P a t i e n t ’s history of smoking was
not systematically recorded in the original patient
records, and no data on smoking were collected. In Fin-
land, however, smoking is more common in elderly men
than in elderly women [16]. One explanation for the
excess male mortality is the assumption that men are
Table 2 Standardized Annual Mortality and Causes of Death in Hip Fracture Patients and Population 1999-2007*
Patients (1,593 PY) Population (6,089,623 PY) RR
Standardized mortality (95% CI) Mortality
Annual average 172.96 (142.26-203.65) 52.98 3.26
Circulatory system disease 69.82 (50.90-88.74) 25.31 2.76
Malignant neoplasm 26.01 (12.52-39.51) 10.30 2.53
Respiratory system disease 22.95 (11.32-34.59) 4.22 5.44
Dementia, Alzheimer’s disease 17.59 (10.91-24.26) 5.77 3.05
Digestive system disease 13.41 (3.50-23.32) 1.59 8.43
Other 23.17 (12.05-34.29) 5.79 4.00
* Counted per 1000 person years (PY) with 95% confidence intervals (95% CI) in patientsRR = relative risk of death for hip fracture patients compared to the
general population
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after hip fracture surgery (decreased secretion in the air-
ways, impaired activities of daily living, and subsequent
chest complications). In addition, smoking may be
related to another finding of our study. Malignant neo-
plasms were more likely the cause of death for men
than for women. A recent cancer survey in Europe con-
cluded that differences in cancer mortality between
sexes and European countries may be explained by
smoking habits [17].
Some previous studies indicate that patients with heart
disease may be more likely to fall and thus sustain a hip
fracture as a consequence of impaired circulation, but
impaired circulation may also increase the likelihood of
dying after having sustained a fracture [1,15]. Similarly,
patients who are immobilized and those with osteoporo-
s i sf o l l o w i n gas t r o k em a yn o to n l yh a v ea ni n c r e a s e d
risk of falls and fractures, but also an increased risk of
dying following complications related to neurovascular
disease [18]. The reason for the greater risk of death
from circulatory disease in men after hip fracture cannot
be addressed on the basis of the present study. In Fin-
land, coronary heart diseases were previously very com-
mon in middle-aged men, but the occurrence has
decreased over the past 10 to 20 years. In women, these
diseases usually occur at an older age than in men [19].
Hence, circulatory system disease might be more severe
and more long-term in older men than in older women.
Findings from analyses by fracture type showed no dif-
ferences between cervical and trochanteric fracture
patients in mortality or cause of death. In contrast, a
Greek study of 499 hip fracture patients with trochan-
teric fracture predominance (67%) reported higher mor-
tality after trochanteric hip fracture than after cervical
hip fracture at 5 and 10 years after the incident [20].
Their conclusion was that the type of hip fracture was
an independent predictor of long-term mortality in hip
fracture patients. A Danish study of 2674 hip fracture
patients with cervical hip fracture predominance (64%),
however, reported that the mortality rates between cer-
vical and pertrochanteric hip fracture patients were not
significantly different during a mean follow-up of 2.6
years [21].
Rehabilitation of older patients falls under the purview
of primary health care; geriatric rehabilitation is poorly
established in Finland. After surgery, hip fracture
patients are usually referredt ol o c a lh o s p i t a lw a r d sf o r
primary care, where the treatment is conservative with
no special knowledge of modern geriatrics. A Finnish
randomized, controlled intervention study of patients 65
years of age or older sustaining hip fracture showed that
active rehabilitation performed by a geriatric team shor-
tened the total hospital stay after a hip fracture opera-
tion and enhanced the recovery of daily activities [22].
The lack of a geriatric rehabilitation center in the Sata-
kunta area may be one explanation for the high mortal-
ity of hip fracture patients of our report.
T h ea c c u r a c yo fr e g i s t e r i ng severe injuries like hip
fractures is generally good in Finland. The completeness
and accuracy of data from the Finnish Health Care Reg-
ister and the Cause-of-Death Register are suitable for
assessing hip fracture treatment [23]. Complete follow-
ups of both fracture patients and population are
strengths of our study. It may also be assumed that sur-
gical practices, anaesthetics, and postoperative treatment
remained unchanged during the 2-year catchment per-
iod of fracture patients. A control cohort with corre-
sponding age included the whole Finnish population
and its mortality was registered comprehensively. To
our knowledge, such a comparison has not previously
been made in the English literature.
Our study also has several limitations. Persons with
medical and functional deficits are more likely to sustain
hip fracture than healthy people; moreover, they have an
increased mortality risk even without hip fracture. This
m i g h tr e s u l ti na no v e r e s t imated risk of death in hip
fracture patients compared to the general population.
The other problem related to comorbidities might be
the difficulty in identifying the “ultimate” cause of death.
Data on patient comorbidities were retrospectively col-
lected from the original patient records, which are
usually based on the information received from the pre-
vious hospital records, referral documents, and patient
and/or proxy interviews. They may not always be reli-
able or fully comprehensive. We had no information on
the frequency of autopsies in cases and controls or
other possible differences in determination of the cause
of death. In general, autopsies are seldom performed in
older people. Furthermore, we did not have information
on postoperative complications or functional recovery.
According to Vestergaard et al. [1], the major causes of
the excess mortality after fracture were complications
related to the fracture event. Because there are regional
differences of mortality in Finland, patterns of death of
hip fracture patients and the general population in Sata-
kunta should be analyzed in future studies.
Our study analyzed excess mortality, i.e., deaths due to
hip fracture that might be prevented, from the scope of
cause of death. To reduce mortality after hip fracture,
optimal treatment of all major comorbidities should be
emphasized. One measure toward achieving this goal
might be improved treatment after discharge from hos-
pital as primary health care becomes responsible for the
treatment. Specialist medical assessment and manage-
ment of older people with hip fracture before and after
surgery have been recommended [2]. Interventions such
as nutritional supplementation and dietetic assessment,
comprehensive multidisciplinary intervention programs,
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including mortality after hip fracture [24,25]. Further-
more, enrolling specially educated personnel in hospitals
treating fractures might improve the secondary preven-
tion of fractures [26]. Most of these measures, however,
are hospital-focused and long-term cooperation between
primary health care and specialist health care needs to
be enhanced to improve survival after hip fracture.
Conclusion
The present study showed that during the follow-up up
to 9 years, the age- and sex-standardized all-cause mor-
tality of hip fracture patients was 3-fold higher than that
of the general population. A similar trend was observed
for each cause-of-death category.
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